Literature DB >> 21696416

Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease.

S Orimo1, T Uchihara, T Kanazawa, Y Itoh, K Wakabayashi, A Kakita, H Takahashi.   

Abstract

AIMS: We recently demonstrated accumulation of α-synuclein aggregates of the cardiac sympathetic nerve in Parkinson's disease (PD) and a possible relationship between degeneration of the cardiac sympathetic nerve and α-synuclein aggregates. The aim of this study is to determine whether there is a difference in the degenerative process between unmyelinated and myelinated axons of the cardiac nerve.
METHODS: We immunohistochemically examined cardiac tissues from four pathologically verified PD patients, nine patients with incidental Lewy body disease (ILBD) and five control subjects, using antibodies against neurofilament, myelin basic protein (MBP) and α-synuclein. First, we counted the number of neurofilament-immunoreactive axons not surrounded by MBP (unmyelinated axons) and those surrounded by MBP (myelinated axons). Next, we counted the number of unmyelinated and myelinated axons with α-synuclein aggregates.
RESULTS: (i) The percentage of unmyelinated axons in PD (77.5 ± 9.14%) was significantly lower compared to that in control subjects (92.2 ± 2.40%). (ii) The ratio of unmyelinated axons with α-synuclein aggregates to total axons with α-synuclein aggregates in ILBD ranged from 94.4 to 100 (98.2 ± 2.18%). Among axons with α-synuclein aggregates, unmyelinated axons were the overwhelming majority, comprising 98.2%.
CONCLUSION: These findings suggest that in PD unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve, because α-synuclein aggregates accumulate much more abundantly in unmyelinated axons.
© 2011 The Authors. Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society.

Entities:  

Mesh:

Year:  2011        PMID: 21696416     DOI: 10.1111/j.1365-2990.2011.01194.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  18 in total

1.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

Review 2.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

Review 3.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

4.  Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds".

Authors:  Nicholas W Sterling; Ming Wang; Lijun Zhang; Eun-Young Lee; Guangwei Du; Mechelle M Lewis; Martin Styner; Xuemei Huang
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

Review 5.  Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.

Authors:  Dominik Haddad; Ken Nakamura
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

Review 6.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2012-07-12       Impact factor: 10.338

Review 7.  Parkinson's disease as a result of aging.

Authors:  Manuel Rodriguez; Clara Rodriguez-Sabate; Ingrid Morales; Alberto Sanchez; Magdalena Sabate
Journal:  Aging Cell       Date:  2015-02-09       Impact factor: 9.304

8.  Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models.

Authors:  Stefan Kurtenbach; Sonja Wewering; Hanns Hatt; Eva M Neuhaus; Hermann Lübbert
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

9.  Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.

Authors:  Valerie Joers; Kristine Dilley; Shahrose Rahman; Corinne Jones; Jeanette Shultz; Heather Simmons; Marina E Emborg
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 10.  The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging.

Authors:  Manuel Rodriguez; Ingrid Morales; Clara Rodriguez-Sabate; Alberto Sanchez; Rafael Castro; Jose Miguel Brito; Magdalena Sabate
Journal:  Front Neuroanat       Date:  2014-08-07       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.